Literature DB >> 22704091

Sperm banking in the United Kingdom is feasible in patients 13 years old or older with cancer.

David J B Keene1, Yasmin Sajjad, Guy Makin, R M Cervellione.   

Abstract

PURPOSE: Assisted reproductive technologies are increasingly being used to treat infertility. Male adolescents with cancer are particularly encouraged to bank semen to preserve fertility before beginning chemotherapy or radiotherapy. We evaluated the feasibility of semen preservation in 12 to 17-year-old patients with cancer.
MATERIALS AND METHODS: We retrospectively collected data from the sperm banking database at our institution for the years 1995 to 2009. Outcomes measured were histological diagnosis, success rate, sperm concentration and sample volume.
RESULTS: A total of 180 patients with a mean age of 16.1 years (range 13.2 to 17.9) were referred for cryopreservation during the study period. Underlying diagnoses included lymphoma (64 patients), leukemia (50), bone tumors (18), testicular tumors (13), soft tissue sarcoma (13), brain tumor (6), germ cell tumors (6) and other cancers (10). Of the patients 119 (66%) successfully banked sperm. A total of 26 patients did not attend their appointment. Of those who attended 15 (10%) were unable to provide a sample and 20 (13%) had azoospermia. A total of 20 patients died after banking sperm and their specimens were subsequently destroyed.
CONCLUSIONS: Cryopreservation of semen of acceptable quality for future use in assisted conception is feasible for most adolescents from age 13 years onward.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22704091     DOI: 10.1016/j.juro.2012.04.023

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Fertility preservation options for children and adolescents with cancer.

Authors:  Rodrigo L P Romao; Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

2.  Testicular niche required for human spermatogonial stem cell expansion.

Authors:  James F Smith; Pamela Yango; Eran Altman; Shweta Choudhry; Andrea Poelzl; Alberuni M Zamah; Mitchell Rosen; Peter C Klatsky; Nam D Tran
Journal:  Stem Cells Transl Med       Date:  2014-07-18       Impact factor: 6.940

3.  Fertility Preservation Preferences and Perspectives Among Adult Male Survivors of Pediatric Cancer and Their Parents.

Authors:  Daniel M Stein; David E Victorson; Jeremy T Choy; Kate E Waimey; Timothy P Pearman; Kristin Smith; Justin Dreyfuss; Karen E Kinahan; Divya Sadhwani; Teresa K Woodruff; Robert E Brannigan
Journal:  J Adolesc Young Adult Oncol       Date:  2014-06-01       Impact factor: 2.223

4.  Predicting successful sperm retrieval in transfeminine adolescents after testicular biopsy.

Authors:  Angus Peri; Astrid Ahler; Debra Gook; Michele A O'Connell; Harold Bourne; Michael Nightingale; Michelle Telfer; Yasmin Jayasinghe; Ken C Pang
Journal:  J Assist Reprod Genet       Date:  2021-08-23       Impact factor: 3.357

5.  Semen Analysis in Cancer Patients Referred for Sperm Cryopreservation before Chemotherapy over a 15-Year Period in Korea.

Authors:  Ja Yoon Ku; Nam Cheol Park; Tae Gyeong Jeon; Hyun Jun Park
Journal:  World J Mens Health       Date:  2015-04-23       Impact factor: 5.400

Review 6.  Process and Pitfalls of Sperm Cryopreservation.

Authors:  Hamoun Rozati; Thomas Handley; Channa N Jayasena
Journal:  J Clin Med       Date:  2017-09-19       Impact factor: 4.241

Review 7.  Risk factors on testicular function in adolescents.

Authors:  F Cargnelutti; A Di Nisio; F Pallotti; M Spaziani; M G Tarsitano; D Paoli; C Foresta
Journal:  J Endocrinol Invest       Date:  2022-03-14       Impact factor: 5.467

8.  Spermiogram and sperm head morphometry assessed by multivariate cluster analysis results during adolescence (12-18 years) and the effect of varicocele.

Authors:  Fernando Vásquez; Carles Soler; Patricia Camps; Anthony Valverde; Almudena García-Molina
Journal:  Asian J Androl       Date:  2016 Nov-Dec       Impact factor: 3.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.